Risk of Systemic Adverse Events after Intravitreal Bevacizumab,Ranibizumab, and Aflibercept in Routine Clinical Practice |
| |
| Authors: | Maya H. Maloney Stephanie R. Payne Jeph Herrin Lindsey R. Sangaralingham Nilay D. Shah Andrew J. Barkmeier |
| |
| Affiliation: | 1. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota;2. Department of Ophthalmology, Kaiser Permanente, Vacaville, California;3. Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota;4. Yale School of Medicine, Yale University, New Haven, Connecticut;5. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota;6. Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;7. OptumLabs, Cambridge, Massachusetts |
| |
| Abstract: | |
| |
| Keywords: | anti-VEGF aflibercept ranibizumab bevacizumab age-related macular degeneration diabetic retinopathy retinal vein occlusion CI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" confidence interval CVD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" cerebrovascular disease DME" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" diabetic macular edema DRD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" diabetic retinal disease FDA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" Food and Drug Administration HR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" hazard ratio ICD-9" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" International Classification of Diseases 9th Revision ICD-10" },{" #name" :" keyword" ," $" :{" id" :" kwrd0125" }," $$" :[{" #name" :" text" ," _" :" International Classification of Diseases 10th Revision IQR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0135" }," $$" :[{" #name" :" text" ," _" :" interquartile range MI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0145" }," $$" :[{" #name" :" text" ," _" :" myocardial infarction nAMD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0155" }," $$" :[{" #name" :" text" ," _" :" neovascular age-related macular degeneration RVO" },{" #name" :" keyword" ," $" :{" id" :" kwrd0165" }," $$" :[{" #name" :" text" ," _" :" retinal vein occlusion SAE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0175" }," $$" :[{" #name" :" text" ," _" :" systemic adverse event VEGF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0185" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
